Yalin Tu

915 total citations
18 papers, 505 citations indexed

About

Yalin Tu is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Yalin Tu has authored 18 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Yalin Tu's work include Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Photosynthetic Processes and Mechanisms (3 papers). Yalin Tu is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Photosynthetic Processes and Mechanisms (3 papers). Yalin Tu collaborates with scholars based in China, Hong Kong and United States. Yalin Tu's co-authors include Jingkao Chen, Rongbiao Pi, Xiaohong Yang, Qiuhe Chen, Yifan Han, Shengnan Wang, Xiao Zhang, Zhaowei Sun, Minghua Jin and Shijun Wen and has published in prestigious journals such as Journal of Cell Science, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Yalin Tu

18 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yalin Tu China 11 248 89 79 74 53 18 505
Pei-Chun Chang Taiwan 15 299 1.2× 85 1.0× 113 1.4× 89 1.2× 50 0.9× 30 601
Jiankang Fang Macao 11 243 1.0× 73 0.8× 58 0.7× 64 0.9× 44 0.8× 16 484
Cosimo Walter D’Acunto Italy 15 352 1.4× 76 0.9× 68 0.9× 31 0.4× 80 1.5× 18 588
Xanthi Antoniou Italy 10 280 1.1× 188 2.1× 106 1.3× 67 0.9× 79 1.5× 12 550
Deborah Pietrobono Italy 15 185 0.7× 137 1.5× 49 0.6× 30 0.4× 24 0.5× 28 479
Ian Gurrell United Kingdom 11 176 0.7× 96 1.1× 39 0.5× 63 0.9× 17 0.3× 14 402
HyunHee Park South Korea 13 227 0.9× 139 1.6× 129 1.6× 60 0.8× 41 0.8× 14 534
Pontus Forsell Sweden 16 347 1.4× 117 1.3× 39 0.5× 108 1.5× 51 1.0× 27 694
Amos C. Hung Taiwan 17 327 1.3× 173 1.9× 60 0.8× 63 0.9× 98 1.8× 33 749

Countries citing papers authored by Yalin Tu

Since Specialization
Citations

This map shows the geographic impact of Yalin Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalin Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalin Tu more than expected).

Fields of papers citing papers by Yalin Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yalin Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalin Tu. The network helps show where Yalin Tu may publish in the future.

Co-authorship network of co-authors of Yalin Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Yalin Tu. A scholar is included among the top collaborators of Yalin Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yalin Tu. Yalin Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ni, Ying, et al.. (2024). A SCYL2 gene from Oryza sativa is involved in phytosterol accumulation and regulates plant growth and salt stress. Plant Science. 343. 112062–112062. 5 indexed citations
4.
Liu, Tian, Yubing Wang, Yiwei Wang, et al.. (2022). The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma. Cancer Letters. 549. 215914–215914. 21 indexed citations
5.
Yang, Yang, Yalin Tu, Junfeng Lu, et al.. (2022). PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: Involvement of PTBP1/PKM1/2 pathway. European Journal of Pharmacology. 920. 174837–174837. 8 indexed citations
6.
Wu, Feng, Liangliang Xu, Yalin Tu, et al.. (2021). Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis. Cancer Letters. 525. 115–130. 27 indexed citations
7.
Tu, Yalin, Shuang Qiao, Yao Luo, et al.. (2021). Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma. Journal of Medicinal Chemistry. 64(14). 10167–10184. 67 indexed citations
8.
Chen, Qiuhe, Yalin Tu, Shinghung Mak, et al.. (2020). Discovery of a novel small molecule PT109 with multi-targeted effects against Alzheimer's disease in vitro and in vivo. European Journal of Pharmacology. 883. 173361–173361. 9 indexed citations
9.
Tu, Yalin, Jing Lü, Panxia Wang, et al.. (2019). Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway. Journal of Cell Science. 132(10). 33 indexed citations
10.
Li, Kaishu, et al.. (2017). IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway. Oncotarget. 8(17). 28865–28879. 20 indexed citations
11.
Li, Kaishu, Yalin Tu, Qingyu Liu, et al.. (2017). PT93, a novel caffeic acid amide derivative, suppresses glioblastoma cells migration, proliferation and MMP-2/−9 expression. Oncology Letters. 13(3). 1990–1996. 8 indexed citations
12.
Chen, Jingkao, Zhaowei Sun, Minghua Jin, et al.. (2017). Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway. Journal of Neuroimmunology. 305. 108–114. 108 indexed citations
13.
Chen, Jingkao, Wei Yin, Yalin Tu, et al.. (2017). L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF-κB inhibition and Nrf2 pathway activation. European Journal of Pharmacology. 806. 1–9. 47 indexed citations
14.
Zhang, Xiao, Ying Wang, Shengnan Wang, et al.. (2017). Discovery of a novel multifunctional carbazole–aminoquinoline dimer for Alzheimer's disease: copper selective chelation, anti-amyloid aggregation, and neuroprotection. Medicinal Chemistry Research. 27(3). 777–784. 15 indexed citations
15.
Chen, Ziwei, Maria Digiacomo, Yalin Tu, et al.. (2016). Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease. European Journal of Medicinal Chemistry. 125. 784–792. 59 indexed citations
16.
Yang, Xiaohong, Ying Ouyang, Yalin Tu, et al.. (2016). Garcinone D, a natural xanthone promotes C17.2 neural stem cell proliferation: Possible involvement of STAT3/Cyclin D1 pathway and Nrf2/HO-1 pathway. Neuroscience Letters. 626. 6–12. 22 indexed citations
17.
Tu, Yalin, et al.. (2016). Discovery of lipoic acid-4-phenyl-1H-pyrazole hybrids as novel bifunctional ROCK inhibitors with antioxidant activity. RSC Advances. 6(63). 58516–58520. 7 indexed citations
18.
Chu, Jiaqi, et al.. (2015). Effects of melatonin and its analogues on neural stem cells. Molecular and Cellular Endocrinology. 420. 169–179. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026